Tirzepatide (Mounjaro, Zepbound) 4.5.1
Lu J, Zou S, Liu X, Wong TYP, Zhang X, Xu KS, Zhao Y, Hong Y, Cen A, Wang Y
Not to be confused with total depigmentation (often risky), moderate bleaching or lightening is more common and generally better managed
Abstract The unprecedented clinical success of glucagon-like peptide-1 (GLP-1) receptor agonists has transformed the therapeutic landscape for obesity, diabetes, and cardiometabolic disease, while simultaneously reshaping long-standing perceptions of peptide-based therapeutics as biologically compelling but pharmacologically impractical
A printed dosing instruction sheet